CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GlaxoSmithKline Pharmaceuticals Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GlaxoSmithKline Pharmaceuticals Limited
Dr Annie Besant Road, Worli
Phone: +91 2224959595p:+91 2224959595 MUMBAI, 400030  India Fax: +91 2224981526f:+91 2224981526

This company was Merged or Acquired on 3/10/2014.
This is a Subsidiary, click here for the Parent Company

Business Summary
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company's manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20193/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Deepak S.Parekh 75
Chief Financial Officer, Whole Time Director PujaThakur 1/1/2018 1/1/2018
Executive Vice President– Pharmaceuticals D.Bartaria 12/31/2015 12/31/2015
12 additional Officers and Directors records available in full report.

Business Names
Business Name
500660
GLAXO
GlaxoSmithKline Pharmaceuticals (India)
GLXKY

General Information
Number of Employees: 4,960 (As of 3/31/2019)
Outstanding Shares: 169,410,000 (As of 9/30/2019)
Shareholders: 98,524
Stock Exchange: NSE
Fax Number: +91 2224981526


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 15, 2019